Cullinan Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC CGEM

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

436,273

Value ($000)

4,515

Weight

0.0%

2021 Q1 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	4,515	0.0%	436,273	12/31/2025
2025 Q3	11/10/2025	2,388	0.0%	402,638	9/30/2025
2025 Q2	8/12/2025	3,279	0.0%	435,516	6/30/2025
2025 Q1	9/15/2025	3,212	0.0%	424,262	3/31/2025
2024 Q4	2/6/2025	5,249	0.0%	430,971	12/31/2024
2024 Q3	11/12/2024	7,097	0.0%	423,959	9/30/2024
2024 Q2	8/12/2024	6,464	0.0%	370,631	6/30/2024
2024 Q1	5/9/2024	4,394	0.0%	257,873	3/31/2024
2023 Q4	2/6/2024	2,514	0.0%	246,705	12/31/2023
2023 Q3	11/8/2023	2,081	0.0%	229,986	9/30/2023
2023 Q2	8/10/2023	1,999	0.0%	185,786	6/30/2023
2023 Q1	5/12/2023	1,918	0.0%	187,533	3/31/2023
2022 Q4	2/13/2023	2,327	0.0%	220,566	12/31/2022
2022 Q3	11/14/2022	2,789	0.0%	217,538	9/30/2022
2022 Q2	8/15/2022	2,382	0.0%	185,773	6/30/2022
2022 Q1	5/13/2022	1,866	0.0%	178,150	3/31/2022
2021 Q4	2/11/2022	2,689	0.0%	174,213	12/31/2021
2021 Q3	11/16/2021	3,854	0.0%	170,744	9/30/2021
2021 Q2	8/16/2021	2,310	0.0%	89,699	6/30/2021
2021 Q1	5/17/2021	3,602	0.0%	86,431	3/31/2021